Zarrabi M H, Rosner F, Grünwald H W
Cancer. 1983 Nov 1;52(9):1712-9. doi: 10.1002/1097-0142(19831101)52:9<1712::aid-cncr2820520927>3.0.co;2-i.
The authors reviewed 61 reported cases of second neoplasms in acute lymphoblastic leukemia (ALL), including 17 patients with ALL followed by another type of acute leukemia, 12 patients with ALL followed by chronic myelocytic leukemia, 19 patients with ALL followed by lymphoma, and 13 patients with ALL followed by other solid tumors. From a review of the literature, it is believed that there is no firm evidence yet that patients with ALL, intensively treated with chemotherapy and/or radiotherapy, are at increased risk of developing therapy-related second neoplasms. Because the number of cases reported is small, there is even insufficient data to firmly suggest that acute myeloblastic leukemia, following intensive therapy for ALL, occurs in a higher-than-expected frequency.
作者回顾了61例急性淋巴细胞白血病(ALL)继发第二肿瘤的报告病例,其中17例ALL患者继发另一种类型的急性白血病,12例ALL患者继发慢性粒细胞白血病,19例ALL患者继发淋巴瘤,13例ALL患者继发其他实体瘤。从文献回顾来看,尚无确凿证据表明接受强化化疗和/或放疗的ALL患者发生与治疗相关的第二肿瘤的风险增加。由于报告的病例数较少,甚至没有足够的数据能确凿地表明,ALL强化治疗后急性髓细胞白血病的发生频率高于预期。